Li S - Search Results

1

Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.

Chen W, Wang LL, Liu HY, Long L, Li S. Chen W, et al. Among authors: li s. Basic Clin Pharmacol Toxicol. 2008 Sep;103(3):240-6. doi: 10.1111/j.1742-7843.2008.00268.x. Epub 2008 Jul 18. Basic Clin Pharmacol Toxicol. 2008. PMID: 18684227 Free article.

2

P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.

Chen W, Zhou XB, Liu HY, Xu C, Wang LL, Li S. Chen W, et al. Among authors: li s. Br J Pharmacol. 2009 Jul;157(5):724-35. doi: 10.1111/j.1476-5381.2009.00231.x. Epub 2009 May 5. Br J Pharmacol. 2009. PMID: 19422369 Free PMC article.

3

Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models.

Chen W, Tang H, Liu H, Long L, Gong Z, Zheng J, Chi M, Xie Y, Zheng Z, Li S, Wang L. Chen W, et al. Among authors: li s. Eur J Pharmacol. 2010 Jul 10;637(1-3):178-85. doi: 10.1016/j.ejphar.2010.03.040. Epub 2010 Apr 7. Eur J Pharmacol. 2010. PMID: 20380831

4

Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats.

Chen W, Chen Z, Xue N, Zheng Z, Li S, Wang L. Chen W, et al. Among authors: li s. Naunyn Schmiedebergs Arch Pharmacol. 2013 Aug;386(8):721-32. doi: 10.1007/s00210-013-0875-y. Epub 2013 Apr 26. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23620336

5

A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice.

Chen W, Gao R, Xie X, Zheng Z, Li H, Li S, Dong F, Wang L. Chen W, et al. Among authors: li s, li h. Sci Rep. 2015 May 6;5:9884. doi: 10.1038/srep09884. Sci Rep. 2015. PMID: 25943561 Free PMC article.

6

C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.

Xu C, Wang LL, Liu HY, Zhou XB, Cao YL, Li S. Xu C, et al. Among authors: li s. Acta Pharmacol Sin. 2006 Feb;27(2):223-8. doi: 10.1111/j.1745-7254.2006.00263.x. Acta Pharmacol Sin. 2006. PMID: 16412273

7

A novel dual peroxisome proliferator-activated receptors alpha and gamma agonist with beneficial effects on insulin resistance and lipid metabolism.

Xu C, Wang LL, Liu HY, Ruan CM, Zhou XB, Cao YL, Li S. Xu C, et al. Among authors: li s. Biotechnol Lett. 2006 Jun;28(12):863-8. doi: 10.1007/s10529-006-9013-y. Epub 2006 May 31. Biotechnol Lett. 2006. PMID: 16786270

8

[Establishment of a diabetic-hypertensive rat model].

Zhang B, Cheng G, Liu HY, Wang LL, Li S. Zhang B, et al. Among authors: li s. Yao Xue Xue Bao. 2009 Jun;44(6):575-80. Yao Xue Xue Bao. 2009. PMID: 19806885 Chinese.

9

(S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl) propanoic acid compounds: synthesis and biological evaluation of dual PPARalpha/gamma agonists.

Zhou X, Chen W, Xu C, Fan S, Xie Y, Zhong W, Wang L, Li S. Zhou X, et al. Among authors: li s. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2605-8. doi: 10.1016/j.bmcl.2010.02.071. Epub 2010 Mar 1. Bioorg Med Chem Lett. 2010. PMID: 20299214

10

Novel selective cannabinoid CB(1) receptor antagonist MJ08 with potent in vivo bioactivity and inverse agonistic effects.

Chen W, Xu C, Liu HY, Long L, Zhang W, Zheng ZB, Xie YD, Wang LL, Li S. Chen W, et al. Among authors: li s. Acta Pharmacol Sin. 2011 Sep;32(9):1148-58. doi: 10.1038/aps.2011.80. Epub 2011 Aug 15. Acta Pharmacol Sin. 2011. PMID: 21841814 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100,641 results

Search Page

Filters